Lancet-话题@MedSci

#Lancet#

4422篇内容 | 14865人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1831496, encodeId=f77b18314960f, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：每4个住院患者就有1个，谵妄对长期认知障碍和死亡率有何影响？, objectType=article, longId=300940, objectId=f68e30094098, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f68e30094098, replyNumber=0, likeNumber=113, createdTime=2022-08-08, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f68e30094098, moduleTitle=Lancet子刊：每4个住院患者就有1个，谵妄对长期认知障碍和死亡率有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f68e30094098)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831589, encodeId=2bd91831589d8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：乌司奴单抗 vs 阿达木单抗治疗克罗恩病头对头研究结果出炉, objectType=article, longId=729675, objectId=dbcee2967524, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbcee2967524, replyNumber=0, likeNumber=124, createdTime=2023-04-16, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbcee2967524, moduleTitle=Lancet：乌司奴单抗 vs 阿达木单抗治疗克罗恩病头对头研究结果出炉, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dbcee2967524)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831367, encodeId=b28a183136ec6, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：SOLO1试验| 奥拉帕利维持治疗晚期卵巢癌随访5年的生存预后, objectType=article, longId=219747, objectId=c80a219e4706, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c80a219e4706, replyNumber=0, likeNumber=125, createdTime=2022-09-18, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c80a219e4706, moduleTitle=Lancet Oncol：SOLO1试验| 奥拉帕利维持治疗晚期卵巢癌随访5年的生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c80a219e4706)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831637, encodeId=6e96183163e24, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle= Lancet子刊：夜晚高温或使死亡风险增加40%-50%, objectType=article, longId=736432, objectId=176ae3643285, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=176ae3643285, replyNumber=0, likeNumber=93, createdTime=2023-05-28, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=176ae3643285, moduleTitle= Lancet子刊：夜晚高温或使死亡风险增加40%-50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=176ae3643285)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831563, encodeId=4f251831563a4, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：Tiragolumab联合阿替利珠单抗作为一线方案治疗PD-L1阳性NSCLC, objectType=article, longId=727300, objectId=7f29e2730032, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f29e2730032, replyNumber=0, likeNumber=94, createdTime=2022-07-02, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f29e2730032, moduleTitle=Lancet Oncol：Tiragolumab联合阿替利珠单抗作为一线方案治疗PD-L1阳性NSCLC, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f29e2730032)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831626, encodeId=b6ba1831626f8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：遵循健康生活方式，慢性呼吸系统疾病死亡风险降低70%, objectType=article, longId=735109, objectId=5953e3510974, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5953e3510974, replyNumber=0, likeNumber=102, createdTime=2023-06-15, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5953e3510974, moduleTitle=Lancet子刊：遵循健康生活方式，慢性呼吸系统疾病死亡风险降低70%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5953e3510974)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831394, encodeId=36f21831394ef, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet：代替缩胃手术，采用可调节的胃内球囊进行减肥的效果, objectType=article, longId=220545, objectId=a1df2205451b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1df2205451b, replyNumber=0, likeNumber=81, createdTime=2022-04-08, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1df2205451b, moduleTitle=Lancet：代替缩胃手术，采用可调节的胃内球囊进行减肥的效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1df2205451b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831383, encodeId=a8441831383c0, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：为打疫苗去三次香港？单剂接种效果如何？, objectType=article, longId=219986, objectId=c6cb21998606, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6cb21998606, replyNumber=0, likeNumber=84, createdTime=2022-07-05, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6cb21998606, moduleTitle=Lancet Oncol：为打疫苗去三次香港？单剂接种效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6cb21998606)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831463, encodeId=9219183146343, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=The Lancet Rheumatology：预测需要全膝关节置换术的风险, objectType=article, longId=295376, objectId=bcf22953e6dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcf22953e6dd, replyNumber=0, likeNumber=0, createdTime=2022-02-22, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcf22953e6dd, moduleTitle=The Lancet Rheumatology：预测需要全膝关节置换术的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcf22953e6dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831402, encodeId=5f2d18314028f, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, objectType=article, longId=221246, objectId=2b0d221246c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0d221246c4, replyNumber=0, likeNumber=76, createdTime=2022-03-24, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0d221246c4, moduleTitle=Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0d221246c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2091581, encodeId=ac3520915816f, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a><a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=神奇食物在这里！每天15g+坚持3个月，体脂减少近5%，血糖耐受性增强！, objectType=article, longId=741667, objectId=4ee1e41667b4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202201002/1664718798644_5490734.jpg, objectUrl=/article/show_article.do?id=4ee1e41667b4, replyNumber=0, likeNumber=131, createdTime=2022-10-03, rootId=0, userName=八骏奔腾, userId=83465314460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee1e41667b4, moduleTitle=神奇食物在这里！每天15g+坚持3个月，体脂减少近5%，血糖耐受性增强！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee1e41667b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831648, encodeId=6e2c1831648ce, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：复旦余宏杰团队揭示Omicron变异株在上海暴发的时空传播特征, objectType=article, longId=738577, objectId=7e71e38577a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e71e38577a6, replyNumber=0, likeNumber=126, createdTime=2022-12-24, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e71e38577a6, moduleTitle=Lancet子刊：复旦余宏杰团队揭示Omicron变异株在上海暴发的时空传播特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e71e38577a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831630, encodeId=208c183163095, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, objectType=article, longId=735293, objectId=8390e3529363, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8390e3529363, replyNumber=0, likeNumber=103, createdTime=2022-12-25, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8390e3529363, moduleTitle=Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8390e3529363)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831414, encodeId=ec35183141442, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Respir Med: ARDS儿童两种炎症表型与预后相关, objectType=article, longId=221780, objectId=95ca221e80f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95ca221e80f4, replyNumber=0, likeNumber=111, createdTime=2022-09-26, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95ca221e80f4, moduleTitle=Lancet Respir Med: ARDS儿童两种炎症表型与预后相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95ca221e80f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831566, encodeId=0da4183156699, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Haematol：鲁索替尼加用Navitoclax治疗骨髓纤维化的分子生物标志物分析, objectType=article, longId=727395, objectId=badde2739538, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=badde2739538, replyNumber=0, likeNumber=91, createdTime=2023-01-25, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=badde2739538, moduleTitle=Lancet Haematol：鲁索替尼加用Navitoclax治疗骨髓纤维化的分子生物标志物分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=badde2739538)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831476, encodeId=989018314e65e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：经济条件决定了该病的预后——全球年轻人糖尿病死亡率和趋势分析, objectType=article, longId=299868, objectId=bcf529986804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcf529986804, replyNumber=0, likeNumber=98, createdTime=2023-01-30, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcf529986804, moduleTitle=Lancet子刊：经济条件决定了该病的预后——全球年轻人糖尿病死亡率和趋势分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcf529986804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831587, encodeId=14ab183158ebf, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后, objectType=article, longId=729046, objectId=d601e290462b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d601e290462b, replyNumber=0, likeNumber=81, createdTime=2022-10-14, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d601e290462b, moduleTitle=Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d601e290462b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831595, encodeId=20751831595be, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet Psychiatry：50年的研究数据——精神分裂症患者教育程度正在改善！, objectType=article, longId=730255, objectId=6aa1e3025532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aa1e3025532, replyNumber=0, likeNumber=82, createdTime=2023-04-19, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aa1e3025532, moduleTitle=Lancet Psychiatry：50年的研究数据——精神分裂症患者教育程度正在改善！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aa1e3025532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831473, encodeId=641818314e332, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：每6秒钟就有一个人因糖尿病死亡，提高收入可以降低死亡风险吗？, objectType=article, longId=295639, objectId=531829563910, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=531829563910, replyNumber=0, likeNumber=120, createdTime=2022-03-10, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=531829563910, moduleTitle=Lancet子刊：每6秒钟就有一个人因糖尿病死亡，提高收入可以降低死亡风险吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=531829563910)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1831512, encodeId=3afc1831512c8, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, objectTitle=Lancet子刊：担心肠癌却又不敢做肠镜？这种替代方法可能同样有效！, objectType=article, longId=301598, objectId=275e30159840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=275e30159840, replyNumber=0, likeNumber=138, createdTime=2022-04-09, rootId=0, userName=howi, userId=3f0227, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=275e30159840, moduleTitle=Lancet子刊：担心肠癌却又不敢做肠镜？这种替代方法可能同样有效！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=275e30159840)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Lancet

2020-05-29

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：每4个住院患者就有1个，谵妄对长期认知障碍和死亡率有何影响？

2022-08-08

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：乌司奴单抗 vs 阿达木单抗治疗克罗恩病头对头研究结果出炉

2023-04-16

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：SOLO1试验| 奥拉帕利维持治疗晚期卵巢癌随访5年的生存预后

2022-09-18

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：夜晚高温或使死亡风险增加40%-50%

2023-05-28

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：Tiragolumab联合阿替利珠单抗作为一线方案治疗PD-L1阳性NSCLC

2022-07-02

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：遵循健康生活方式，慢性呼吸系统疾病死亡风险降低70%

2023-06-15

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet：代替缩胃手术，采用可调节的胃内球囊进行减肥的效果

2022-04-08

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：为打疫苗去三次香港？单剂接种效果如何？

2022-07-05

howi (审核中...)

前往app查看评论内容

#Lancet#

The Lancet Rheumatology：预测需要全膝关节置换术的风险

2022-02-22

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：达拉菲尼联合曲美替尼在BRAFV600E突变阳性胶质瘤中的疗效

2022-03-24

八骏奔腾 (审核中...)

前往app查看评论内容

#Nat##Lancet#

神奇食物在这里！每天15g+坚持3个月，体脂减少近5%，血糖耐受性增强！

2022-10-03

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：复旦余宏杰团队揭示Omicron变异株在上海暴发的时空传播特征

2022-12-24

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：阿特珠单抗+Cobimetinib+Vemurafenib治疗CNS转移的黑色素瘤

2022-12-25

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Respir Med: ARDS儿童两种炎症表型与预后相关

2022-09-26

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Haematol：鲁索替尼加用Navitoclax治疗骨髓纤维化的分子生物标志物分析

2023-01-25

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：经济条件决定了该病的预后——全球年轻人糖尿病死亡率和趋势分析

2023-01-30

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后

2022-10-14

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet Psychiatry：50年的研究数据——精神分裂症患者教育程度正在改善！

2023-04-19

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：每6秒钟就有一个人因糖尿病死亡，提高收入可以降低死亡风险吗？

2022-03-10

howi (审核中...)

前往app查看评论内容

#Lancet#

Lancet子刊：担心肠癌却又不敢做肠镜？这种替代方法可能同样有效！

2022-04-09

科室
- - 订阅+
  - 更多科室
工具
服务